Smart science to improve lives™

Empowering biologics delivery

A world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.

Unlock future therapies with us

Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making, and selling speciality chemicals that are relied on by industries and consumers everywhere. We have a network of over 4,500 passionate and committed employees, working together as one global team across manufacturing sites and offices in 38 countries.

As Croda Pharma, we are committed to empowering biologics delivery. We offer high purity pharmaceutical excipients, world leading vaccine adjuvants, innovative lipids and in-house formulation expertise, making us the ideal partner to navigate drug and vaccine formulation challenges.

Tailored excipient solutions

Create tailored excipient solutions directly in partnership with our scientists. 

We work with you to unlock future therapies through developing the next generation of excipients.

Formulate and troubleshoot faster

Tackle your stability challenges with unparalleled purity excipients across all administration routes.

Formulate and troubleshoot faster by working with our scientific experts during your development.


Prioritise sustainability and integrity by choosing Croda Pharma for your developments.
Our product portfolio is proven to solubilise, stabilise and deliver the most challenging of active pharmaceutical ingredients, while our high investment in GMP and multi-site EXCiPACT accreditation provides confidence in both our excipient quality and supply chain security.

Your pharma solutions partner

image in circle of people working in a lab

High purity excipients

Optimising the performance of formulations to solve your stability and solubility challenges
Image of test tubes and vials

Vaccine adjuvants

Committed to the highest standards, with 80+ years in expertise in adjuvant research and development
circular icon of a chemical manufacturing plant

Innovative lipids

Enabling the delivery and stability of nucleic acid-based vaccines, therapeutics and gene editing technology

Our technology platforms

We’re committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.

Small Molecule Delivery icon
Small Molecule Delivery
Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms.
Protein Delivery icon
Protein Delivery
Addressing the toughest challenges associated with protein-based therapies, our Super Refined™ range of high purity excipients ensures optimal protein stabilisation for enhanced biologic drug delivery.
Nucleic acid icon
Nucleic Acid Delivery
Our Avanti lipids range offers innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
Adjuvant Systems Icon
Adjuvant Systems
We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.

Find out more information:

Family Enjoying Walk In Summer

Consumer Health

Our main goal in Consumer Health is to help our customers market consumer relevant label claims that grow their product and brand authority. We combine our technical expertise with regulatory knowledge to help our customers market innovative products.

Collage mosaic of many happy people couples and families, old young generation adults and kids

Human Pharmaceuticals

We are transforming our business to meet the needs of the pharma industry, committing to product quality, regulatory excellence, and supply chain security.

Vet examining dog and cat.

Veterinary health

We create, make, and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in many types of livestock and companion animal health products.

How we empower biologics delivery

Image of Croda Pharma innovating in a lab

Enabling breakthrough innovation

Dedicated to developing the next generation of excipients and delivery systems to empower biopharma
Female Croda Pharma employee formulating in lab

Access to specialist formulation support

Enabling over 250 on-going clinical projects targeting a range of therapeutic areas across biologics and small molecules
Croda Pharma employee in a lab

Focused scientific expertise

Leading the way with specialist knowledge and synthesis expertise in excipients, adjuvants and lipids

Explore recent blogs:

Sohnke Voss PhD, Croda Pharma

Lipid Leaders: Söhnke Voss

In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...

Read more
andy bright

Protein Delivery Leaders: Andrew Bright

In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.

Read more

Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards

Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...

Read more
lab image

Partnership agreement between Croda and AAHI to drive innovation in vaccine development

19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...

Read more